- Goldman Sachs raised Lowe's Companies, Inc. (NYSE:LOW) price target from $241 to $246. . Goldman Sachs analyst Kate McShane maintained a Buy rating on the stock. Lowe's shares fell 0.1% to $206.70 in pre-market trading.
- Stephens & Co. boosted NCR Corporation (NYSE:NCR) price target from $28 to $32. Stephens & Co. analyst Charles Nabhan maintained an Overweight rating on the stock. NCR rose 0.3% to close at $22.87 on Wednesday.
- Credit Suisse raised the price target on Campbell Soup Company (NYSE:CPB) from $52 to $54. Credit Suisse analyst Robert Moskow maintained a Neutral rating on the stock. Campbell Soup shares fell 0.1% to $56.11 in pre-market trading.
- Raymond James cut GDS Holdings Limited (NASDAQ:GDS) price target from $55 to $35. Raymond James analyst Frank Louthan maintained an Outperform rating on the stock. GDS Holdings shares rose 7.6% to $18.89 in pre-market trading.
- JP Morgan cut Martin Marietta Materials, Inc. (NYSE:MLM) price target from $410 to $395. JP Morgan analyst Adrian Heurta maintained an Overweight rating on the stock. Martin Marietta Materials shares gained 0.7% to close at $352.50 on Wednesday.
- BTIG boosted Prometheus Biosciences, Inc. (NASDAQ:RXDX) price target from $74 to $181. BTIG analyst Julian Harrison maintained a Buy rating on the stock. Prometheus Biosciences shares jumped 9.4% to $104.84 in pre-market trading.
- Oppenheimer cut Mirati Therapeutics, Inc. (NASDAQ:MRTX) price target from $85 to $60. Oppenheimer analyst Jay Olson maintained the stock with a Perform. Mirati Therapeutics Limited shares fell 0.2% to $49.47 in pre-market trading.
- HC Wainwright & Co. cut Gossamer Bio, Inc. (NASDAQ:GOSS) price target from $25 to $5. Gold HC Wainwright & Co. analyst Patrick Trucchio maintained a Buy rating on the stock. Gossamer Bio shares fell 1.8% to $2.12 in pre-market trading.
- Baird cut Salesforce, Inc. (NYSE:CRM) price target from $200 to $150. Baird analyst Rob Oliver downgraded the stock from Outperform to Neutral. Salesforce shares fell 0.9% to $129.37 in pre-market trading.
- Jefferies cut Lumos Pharma, Inc. (NASDAQ:LUMO) price target from $17 to $7. Jefferies analyst Eun Yang downgraded the stock from Buy to Hold. Lumos Pharma shares fell 11.2% to close at $4.46 on Wednesday.
- UBS boosted The Hershey Company (NYSE:HSY) price target from $244 to $269. UBS analyst Cody Ross upgraded the stock from Neutral to Buy. Hershey shares rose 1.2% to $239.61 in pre-market trading.
Check out this: Why These Lululemon Analysts Have Boosted Their Price Targets Ahead Of Earnings